Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer
Journal of Medicinal Chemistry · 08.08.2024 · 67 (15) · 13231-13251
DOI: 10.1021/acs.jmedchem.4c01178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.07.2024. Verfasst von Shengnan Zhou und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangs…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antineoplastic Agents, Coumarins, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Jiangsu Provincial Department of Education, Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Increasing evidence has demonstrated that oxidative phosphorylation (OXPHOS) is closely associated with the progression of pancreatic cancer (PC). Given its central role in mitochondrial transcription, the human mitochondrial RNA polymerase (POLRMT) is a promising target for developing PC treatments. Herein, structure-activity relationship exploration led to the identification of compound S7, which was the first reported POLRMT inhibitor possessing single-digit nanomolar potency of inhibiting PC cells proliferation. Mechanistic studies showed that compound S7 exerted antiproliferative effects without affecting the cell cycle, apoptosis, mitochondrial membrane potential (MMP), or intracellular reactive oxygen species (ROS) levels specifically in MIA PaCa-2 cells. Notably, compound S7 inhibited tumor growth in MIA PaCa-2 xenograft tumor model with a tumor growth inhibition (TGI) rate of 64.52% demonstrating significant improvement compared to the positive control (44.80%). In conclusion, this work enriched SARs of POLRMT inhibitors, and compound S7 deserved further investigations of drug-likeness as a candidate for PC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 211198, P. R. China.
- Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Longmian Avenue 639, Nanjing 211198, China.
ORCID-Profile: Jianbing Wu, Zhenwei Yuan, Jinyi Xu, Xinnan Li, Hong Yao
Förderung
- Jiangsu Provincial Department of Education
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhou, S., Ze, X., Feng, D., Liu, L., Shi, Y., Yu, M., Huang, L., Wang, Y., Men, H., Wu, J., Yuan, Z., Zhou, M., Xu, J., Li, X., & Yao, H. (2024). Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer. Journal of Medicinal Chemistry, 67(15), 13231-13251. https://doi.org/10.1021/acs.jmedchem.4c01178
Vancouver
Zhou S, Ze X, Feng D, Liu L, Shi Y, Yu M, et al. Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer. Journal of Medicinal Chemistry. 2024;67(15):13231-13251. doi:10.1021/acs.jmedchem.4c01178
BibTeX
@article{Zhou2024,
author = {Zhou, Shengnan and Ze, Xiaotong and Feng, Dazhi and Liu, Lihua and Shi, Yuning and Yu, Minghui and Huang, Lijuan and Wang, Yunyue and Men, Hanlu and Wu, Jianbing and Yuan, Zhenwei and Zhou, Mengze and Xu, Jinyi and Li, Xinnan and Yao, Hong},
title = {Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {15},
pages = {13231--13251},
doi = {10.1021/acs.jmedchem.4c01178}
}
EUVIMED